AC Immune ACIU
NASDAQ ACIU
$2.62 +0.02 (+0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

AC Immune (ACIU) Capital Leases (2017 - 2018)

Updated

AC Immune's Capital Leases came in at -$53.26 million for the quarter ended Dec 31, 2018, compared with $206.77 million a year earlier.

Analysis

AC Immune (ACIU) Capital Leases (2017 - 2018) Analysis & Trends

As of Dec 31, 2018, AC Immune's Capital Leases was -$54.2 million.

  • Going back by year, Capital Leases was $207.25 million in the year ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 AC Immune 264.53 Mn 264.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -53.26 Mn
Dec 31, 2017 206.77 Mn
API Access

AC Immune Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ACIU&period=max&api_key=YOUR_API_KEY